Why is the Mesoblast share price on ice today?

Mesoblast is another share placed on pause today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Mesoblast shares are on ice today 
  • The company says it is set to complete a private placement 
  • The Mesoblast share price is down 54% for the last 12 months 

The Mesoblast Limited (ASX: MSB) share price is on pause following a company requested halt to trading of its securities.

The ASX granted the company's request before market open today. Prior to being put on ice, the Mesoblast share price closed yesterday's session at 93 cents apiece.

A dollar sign embedded in ice, indicating a share price freeze or trading halt

Image source: Getty Images

Why is the Mesoblast share price frozen?

It appears the company is gearing up to raise additional capital from equity investors.

In the release, it said it "requests a trading halt in its securities effective immediately pending an announcement…in relation to a proposed private placement."

It is not yet understood what the capital raise is for, or what amount the company is seeking to raise from investors.

However, it intends to make the impending announcement between now and 8 August, when the trading halt will then be lifted.

Mesoblast shares have caught a bid lately and are now up more than 36% over the past month of trading, as seen in the chart below.

This gain is in line with the broad healthcare sector, which has realized similar levels of upside in the new financial year.

TradingView Chart

Despite this, the Mesoblast share price is down 54% for the last 12 months or 34% this year to date

More on Healthcare Shares

Young businesswoman sitting in kitchen and working on laptop.
Healthcare Shares

Up 15% in a week, is it too late to buy rebounding CSL shares?

CSL shares trade on roughly 13 times forecast FY26 earnings and offer a good dividend yield.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Broker Notes

Down 60%, are Cochlear shares now a bargain buy?

A leading analyst provides his outlook for Cochlear’s beaten-down shares.

Read more »

Young woman thinking with laptop open.
Healthcare Shares

Why are Sigma Healthcare shares in the spotlight this week?

Is the latest sell-off overdone?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Is it time to get greedy with Pro Medicus shares?

The company was swept up in the huge sector-wide downturn in late 2025 and early 2026 as investors turned their…

Read more »

Young doctor raising arms in air with hands in fists celebrating a new development.
Healthcare Shares

Prediction: I think Telix shares could double in value in 2026. Here's why

The biopharmaceutical company's shares dipped to a three-year low in February, but have now rebounded strongly.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

How much does UBS think CSL will bounce back?

If the worst is over, what's the upside for the shares?

Read more »

Woman with long hair smiles for the camera.
Healthcare Shares

Why I'd buy CSL shares while sentiment is weak

The market no longer treats this ASX healthcare giant as flawless, and that may make the investment case more interesting.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Is this exciting healthcare stock a buy, hold or sell after rocketing 16% yesterday?

Can this soaring stock keep rising?

Read more »